bims-celmim Biomed News
on Cellular and mitochondrial metabolism
Issue of 2026–11–15
27 papers selected by
Marc Segarra Mondejar, AINA



  1. Nat Commun. 2026 10 13. pii: 11577. [Epub ahead of print]17(1):
      Impaired adipogenesis contributes to obesity-associated metabolic disorders, in which mitochondrial dysfunction plays an important role. Emerging evidence suggests that mitochondria-localized circular RNAs (circRNAs) influence mitochondrial function; however, whether they regulate adipogenesis and systemic metabolism is unclear. By profiling circRNAs in mitochondria isolated from the white adipose tissue (WAT) of obese male mice, we observe an upregulation of Birc6-circRNA Repressing Adipogenesis and Krebs-cycle Energy (BRAKE) in mitochondria. In vivo, adipocyte-specific circRNA BRAKE knockdown in male mice reduces body weight, restricts fat expansion, and improves insulin sensitivity. In vitro studies show that circRNA BRAKE inhibits adipogenesis. Mechanistically, circRNA BRAKE binds ATP5A and disrupts ATP synthase assembly, thereby reducing ATP production and mTORC1 signaling and suppressing adipogenesis. In omental WAT (oWAT) of patients with obesity, mitochondrial circRNA BRAKE levels are elevated and inversely correlated with mitochondrial bioenergetic function. Collectively, our data identify a mitochondria-localized circRNA that regulates energy metabolism and adipogenesis, suggesting that circRNA BRAKE may represent a potential therapeutic target for obesity-related metabolic diseases.
    DOI:  https://doi.org/10.1038/s41467-026-78378-z
  2. Cancer Cell Int. 2026 Aug 14. pii: 358. [Epub ahead of print]26(1):
      Solute carrier (SLC) transporters play a central role in tumor metabolism by mediating the uptake of amino acids and sugars required for cancer cell growth and survival. Their proper function is crucial for maintaining cellular homeostasis, and their dysregulation contributes to metabolic reprogramming, tumor progression, and therapy resistance. Recent studies have identified non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, as key regulators of SLC transporter expression and function. This review provides a focused and comprehensive overview of the intricate regulatory networks between ncRNAs and amino acid and sugar transporters within the SLC family, highlighting their implications in cancer. We summarize current evidence on direct and indirect regulatory mechanisms, including transcriptional, post-transcriptional, and epigenetic pathways, and discuss how these interactions reshape cancer metabolism. We highlight existing knowledge gaps, such as context-dependent regulation, indirect regulatory networks, and limited mechanistic validation in vivo. Finally, we discuss the therapeutic potential and challenges of targeting ncRNA-SLC networks. A deeper understanding of these interactions may facilitate the development of novel therapeutic approaches aimed at improving cancer treatment outcomes.
    Keywords:   Amino acid transporters; Cancer metabolism; Glucose transporters; Non-coding RNA (ncRNA); Solute carrier (SLC)
    DOI:  https://doi.org/10.1186/s12935-026-04431-y
  3. Mol Cell. 2026 Nov 12. pii: S1097-2765(26)00742-2. [Epub ahead of print]
      Perturbed glucose homeostasis is a hallmark of metabolic disease and cancer, and cellular responses to excess glucose are tightly controlled. We report here a lysosomal glucose sensing axis linking the transporter GLUT1 with the lysosomal protein DRAM1. Pathophysiological glucose induces DRAM1 via the MLX/ChREBP transcriptional complex. DRAM1 then binds newly synthesized GLUT1 and promotes its traffic to lysosomes without degradation, reducing surface GLUT1 and acting as a reversible brake on glucose entry. Hexokinase or glucose-6-phosphate (G6P) dehydrogenase disruption weakens DRAM1-GLUT1 complex formation, whereas nicotinamide adenine dinucleotide phosphate(NADPH) oxidase (NOX) inhibition enhances assembly, implicating NADPH as a key metabolic signal downstream of elevated glucose. Sequestration of GLUT1 suppresses glucose uptake and glycolysis and rewires metabolism toward glutamine anaplerosis, creating vulnerability to glutaminase (GLS) inhibition. In vivo, Dram1-/- tumors display a glycolytic metabolite profile, consistent with loss of this brake. Together, these data define an mTORC1- and AMPK-independent lysosomal mechanism that protects metabolic homeostasis under hyperglycemic conditions.
    Keywords:  DRAM1; GLUT1; NADPH; glucose sensing; glutamine anaplerosis; hyperglycemia; lysosomes; metabolism
    DOI:  https://doi.org/10.1016/j.molcel.2026.10.022
  4. PLoS One. 2026 ;21(11): e0361879
      Hepatocellular carcinoma (HCC) is characterized by profound metabolic reprogramming that supports tumor initiation, growth, and metastasis. Understanding how metabolic profiles differ between normal hepatocytes and HCC cells with distinct aggressive phenotypes may help identify metabolic features associated with tumor progression. The Dt81Hepa1-6 cell line, derived from the murine Hepa1-6 hepatoma line, exhibits increased aggressiveness and provides a useful model for investigating metabolic features associated with aggressive behavior. We performed an integrative 1H NMR-based metabolomic analysis of intracellular extracts (endometabolome) and extracellular culture media (exometabolome) from primary hepatocytes, Hepa1-6, and Dt81Hepa1-6 cells collected at 24h and 48h. Multivariate statistical analyses, including PCA and PLS-DA, were used to characterize metabolic differences among the three cell types. Metabolic profiling revealed a clear separation between primary hepatocytes and HCC cells in both endometabolomic and exometabolomic datasets. HCC cells exhibited increased lactate and alanine levels together with decreased intracellular glucose and glutathione, consistent with altered glycolytic and redox metabolism. Time-dependent changes in glucose consumption and lactate release were prominent in extracellular media from both HCC cell lines. The aggressive Dt81Hepa1-6 line displayed a distinct metabolic phenotype characterized by increased extracellular pyroglutamate, citrate, formate and particularly BCAA-derived ketoacids, 2-oxo-isovalerate and 3-methyl-2-oxovalerate. These findings are consistent with alterations in BCAA-associated metabolism, glutamine/glutamate, and TCA-related metabolism in the more aggressive cell line. Overall, the integration of endometabolomic and exometabolomic 1H NMR profiling identifies metabolic features associated with the aggressive phenotype of Dt81Hepa1-6 cells. BCAA-derived ketoacids, pyroglutamate, and TCA-related metabolites emerge as candidate metabolic features that warrant validation in additional experimental and clinical HCC models.
    DOI:  https://doi.org/10.1371/journal.pone.0361879
  5. Nat Commun. 2026 10 14. pii: 11622. [Epub ahead of print]17(1):
      Accessible cholesterol, the pool of membrane cholesterol with high chemical activity, regulates vital processes including vertebrate development and pathogen evasion. The mechanisms that govern plasma membrane (PM) cholesterol accessibility are incompletely understood. Using a genome-wide screen we find that acetyl-CoA carboxylase alpha (ACC1) loss causes a ~10-fold increase in PM accessible cholesterol in cells and a male mouse model. We demonstrate that reduced fatty acyl-CoA levels, achieved by targeting metabolic enzymes including ACC1, fatty acid synthase (FASN) or acyl-CoA synthetases long chain (ACSL1, 3 and 4), results in the activation of adipose triacylglycerol lipase (ATGL). ATGL activation elevates polyunsaturated diacylglycerols even in triacylglycerol-deficient backgrounds, suggesting that ATGL acts independently of triacylglycerol hydrolysis. These diacylglycerol species are utilized to generate polyunsaturated phosphatidylcholine and phosphatidylethanolamine, which raises PM fluidity and cholesterol accessibility. Conversely, ATGL inhibition rigidifies the PM, reducing PM accessible cholesterol. Increased PM fluidity impairs cholesterol transport, triggering SREBP2 activation. This study reveals a surprising link between fatty acid metabolism and cholesterol homeostasis, demonstrating how ATGL-dependent lipid remodeling tunes membrane fluidity to regulate intracellular cholesterol signaling.
    DOI:  https://doi.org/10.1038/s41467-026-78470-4
  6. Elife. 2026 Nov 11. pii: RP109761. [Epub ahead of print]15
      Mitochondrial dysfunction and declining ATP production are common features of aging, yet whether ATP availability itself directly regulates cellular lifespan is unclear. However, the causal relationship between cellular ATP homeostasis and aging has not been established. Here, we developed a synthetic system to manipulate intracellular ATP independently of endogenous energy production by expressing a plasma membrane-targeted nucleotide transporter, NTT1, from the intracellular parasite Encephalitozoon cuniculi in Saccharomyces cerevisiae. NTT1 expression depleted intracellular ATP in the absence of extracellular ATP, whereas ATP supplementation produced robust NTT1-dependent ATP uptake, and increased intracellular ATP abundance. ATP availability strongly influenced replicative lifespan: ATP depletion shortened lifespan, whereas ATP supplementation restored and extended lifespan in NTT1-expressing cells. Unexpectedly, extracellular ATP also extended lifespan in wild-type cells that lack ATP import, revealing an NTT1-independent response to extracellular ATP. Transcriptomic analyses showed that NTT1-mediated ATP import suppresses glucose uptake, carbohydrate catabolism, mitochondrial respiration, and autophagy, whereas extracellular ATP elicits a distinct transcriptional response in wild-type cells involving metabolic, mitochondrial, and signaling pathways. Single-cell aging analyses further showed that ATP supplementation extends lifespan across distinct aging trajectories and shifts cells away from the mitochondrial dysfunction-associated aging state. Finally, experiments in cells lacking mitochondrial DNA separated these effects mechanistically: NTT1-associated lifespan phenotypes and high-ATP toxicity required functional mitochondria, whereas extracellular ATP extended lifespan in wild-type cells independently of mitochondrial respiration. Together, these findings demonstrate that ATP availability is a direct regulator of cellular aging and reveal distinct metabolic and extracellular ATP-responsive routes through which cellular energy state influences longevity.
    Keywords:  ATP; S. cerevisiae; aging; cell biology; energy metabolism; mitochondria; nucleotide transport; yeast
    DOI:  https://doi.org/10.7554/eLife.109761
  7. Cell Death Dis. 2026 Aug 18. pii: 964. [Epub ahead of print]17(1):
      The translocator protein (TSPO) is an evolutionarily conserved 18 kDa protein localised to the outer mitochondrial membrane and increasingly recognised as a multifunctional regulator of cellular homeostasis. Although initially identified as the peripheral benzodiazepine receptor, TSPO has since been implicated in a range of mitochondrial processes. This review integrates current evidence on TSPO function across evolution and in mammalian systems, with a focus on its interactions with mitochondrial gatekeeping proteins. TSPO has been implicated in regulating cholesterol transport, redox homeostasis, calcium (Ca2+) signalling, and mitochondrial quality control. Mechanistically, TSPO has been proposed to modulate Ca2+ flux and reactive oxygen species (ROS) production through VDAC1-associated pathways, linking mitochondrial dynamics to cellular stress responses. We also evaluate the context-dependent effects of TSPO ligands across disease models. Collectively, these findings position TSPO as a potential integrator of mitochondrial signalling with important implications for understanding disease mechanisms and therapeutic targeting.
    DOI:  https://doi.org/10.1038/s41419-026-09126-w
  8. Dev Cell. 2026 Nov 11. pii: S1534-5807(26)00395-3. [Epub ahead of print]61(11): 2193-2212.e8
      p53 protects against the initiation and progression of cancers, but the mechanisms underlying this function remain incompletely understood. Chaperone-mediated autophagy (CMA) is a form of autophagy unique in vertebrates, yet its regulation and function are unclear. Here, we demonstrate that p53 functions as a central activator of CMA, integrating stress signals to regulate this selective autophagic pathway. Mechanistically, the energy sensor AMP-activated protein kinase (AMPK) inhibits CMA by preventing oligomerization of its receptor LAMP2A. Cytoplasmic p53 interacts with AMPK and relieves this inhibition. By activating CMA, p53 promotes lysosomal degradation of isocitrate dehydrogenases IDH1 and IDH2, thereby reducing intracellular α-ketoglutarate levels, inhibiting reductive glutamine metabolism, and suppressing growth of lung and liver cancers. Tumor-associated p53 mutants fail to promote CMA, whereas oncogenic IDH1/2 mutants evade CMA-mediated degradation. These results suggest that CMA activation may be a fundamental component of p53 function, through which it modulates metabolism and inhibits oncogenic growth.
    Keywords:  AMPK; CMA; IDH1; IDH2; LAMP2A; autophagy; chaperone-mediated autophagy; p53; reductive carboxylation; α-ketoglutarate
    DOI:  https://doi.org/10.1016/j.devcel.2026.10.009
  9. Cell Rep. 2026 Nov 10. pii: S2211-1247(26)01396-3. [Epub ahead of print]45(11): 118317
      Metabolic reprogramming is a hallmark of cancer and involves alterations in glucose metabolism. Increasing evidence shows that acylation modifications mediated by metabolic intermediates play vital roles in cancer progression. Toward understanding the lysine succinylation (Ksu) that regulate pancreatic ductal adenocarcinoma (PDAC) development, we conduct a comprehensive succinylproteome study on a prospectively collected PDAC cohort. Succinylome integration identifies a range of dysregulated Ksu sites closely associated with metabolic perturbations. Moreover, cross-talk analysis of Ksu and lysine lactylation (Kla) reveals the functional roles of Ksu in proteins specifically related to the fatty acid β-oxidation (FAO), among which, the succinylation at lysine 115 (K115su) of short-chain enoyl-CoA hydratase 1 (ECHS1) is downregulated in pancreatic cancer. It is further verified that K115su reduces the conversion of ECHS1 for its substrate, thereby inhibiting FAO metabolism. Therefore, our study delineates multiple cancer-specific Ksu sites and unravels the significance of ECHS1 K115su in PDAC progression.
    Keywords:  CP: cancer; CP: metabolism; ECHS1; Metabolic reprogramming; lactylation; pancreatic ductal adenocarcinoma; succinylation
    DOI:  https://doi.org/10.1016/j.celrep.2026.118317
  10. Cell Mol Neurobiol. 2026 Aug 12. pii: 162. [Epub ahead of print]46(1):
      Mitochondrial dysfunction is a central pathogenic mechanism in Parkinson's disease (PD), yet early mitochondrial events linking respiratory impairment to neuronal vulnerability remain incompletely defined. Here, we investigated the impact of acute and chronic exposure to subtoxic and toxic doses of the mitochondrial Complex I inhibitor rotenone on oxidative stress, mitochondrial bioenergetics/metabolism, and mitochondrial dynamics in primary cortical neurons. Using live-cell imaging, bioenergetics and metabolomic profiling, we show that nanomolar concentrations of rotenone rapidly induce accumulation of reactive oxygen species (ROS), lipid peroxidation, and loss of mitochondrial membrane potential preceding overt neuronal death. Notably, high-content morphometric analysis revealed that even subtoxic doses of rotenone trigger an early structural remodeling characterized by mitochondrial network fragmentation into small spherical puncta (0.5-3 μm) and localized organelle swelling at both neuritic and synaptic levels. Instead, at the molecular level, whole-cell biochemical degradation of mitochondrial remodeling proteins, suppression of regulated, physiological fission-fusion cycling and accumulation of the autophagy adaptor SQSTM1/p62, indicative of defective quality control, fully manifest only at higher, toxic rotenone concentrations. Furthermore, subtoxic doses elicit widespread metabolic alterations including persistent redox imbalance, impaired glutathione (GSH) biosynthesis, and downregulation of anabolic processes such as folate/one-carbon and amino sugar metabolism. Collectively, our findings newly reveal that localized mitochondrial morphometric remodeling and metabolic pathway rewiring represent early, interconnected adaptive responses to complex I impairment, contributing to the baseline thresholds of neuronal vulnerability in PD models.
    Keywords:  Metabolite set enriched analysis (MSEA); Metabolomics; Mitochondrial bioenergetics; Mitochondrial dynamics; Oxidative stress; Parkinson’s disease
    DOI:  https://doi.org/10.1007/s10571-026-01794-8
  11. Nat Metab. 2026 Nov 13.
      Brown adipose tissue (BAT) is a cold-activated organ that uncouples mitochondrial respiration from ATP synthesis to produce heat. Activated BAT can consume an extreme amount of glucose, per gram of tissue, in both mice and humans. However, the contexts, mechanisms and necessity for BAT glucose utilization remain surprisingly undefined in vivo. Here we show that while BAT thermogenesis is maintained across diverse dietary contexts, its glucose utilization is particularly responsive to diet. Importantly, we find cold-induced BAT glucose uptake and thermogenesis to be independent of the previously proposed critical transporter, GLUT1. Instead, inducible GLUT4 loss eliminates cold-induced glucose uptake and compromises BAT thermogenesis only when dietary lipids are low during cold stress. We furthermore illustrate the unexpected capacity for brown adipocytes to sustain ATP levels without glycolysis, even during substantial mitochondrial uncoupling, when alternative nutrients are abundant. Collectively, our work demonstrates that BAT sustains thermogenesis through marked metabolic flexibility across nutrient contexts.
    DOI:  https://doi.org/10.1038/s42255-026-01652-3
  12. Mol Metab. 2026 Nov 11. pii: S2212-8778(26)00156-0. [Epub ahead of print] 102472
      Mitochondrial diseases are a heterogeneous group of genetic disorders caused by impaired oxidative phosphorylation (OxPhos). When skeletal muscle is predominantly affected, they are defined as primary mitochondrial myopathies. Although the genetic causes of mitochondrial myopathies and the resulting bioenergetic impairments are well established, the metabolic drivers behind progressive muscle dysfunction remain poorly defined. This gap in knowledge may contribute to the lack of effective treatments for these disorders. OxPhos defective muscle initiates a metabolic response coordinated by systemic signals which results in muscle and adipose tissue wasting. Here, we show ectopic muscle lipid accumulation in a COX10 KO mouse model of mitochondrial myopathy due to inability to oxidize fatty acids in muscle. In both the mouse model and in mitochondrial patients, we find an increase in ceramides, which is mechanistically linked to chronic ER stress, phosphorylation of eIF2α, and activation of ATF4 signaling. We propose that Ph-eIF2α-mediated attenuation of global protein synthesis and ATF4-initiated atrophy pathways contribute to muscle wasting and weakness. Importantly, inhibition of de novo synthesis of ceramides with myriocin reduces ER stress and ATF4 signaling and improves muscle proteostasis, body weight, and motor functions in the COX10 KO mouse. Together, these findings highlight the role of lipid metabolism as a contributor to mitochondrial myopathy and identify lipid-mediated stress pathways that can be targeted therapeutically.
    Keywords:  COX10; ER stress; ceramides; lipid metabolism; mitochondrial myopathy; muscle wasting
    DOI:  https://doi.org/10.1016/j.molmet.2026.102472
  13. STAR Protoc. 2026 Nov 10. pii: S2666-1667(26)00611-8. [Epub ahead of print]7(4): 104958
      In vivo adenosine triphosphate (ATP) imaging is a powerful approach for studying physiological and pathological mechanisms underlying various metabolic processes. Here, we present a protocol for multiscale in vivo ATP imaging using AVID (ATP visualization in vivo directly) mice, which express GO-ATeam2, a fluorescent biosensor. We describe steps for endotracheal intubation, mechanical ventilation, and imaging preparation. We then detail procedures for macroscopic or two-photon imaging and image analysis.
    Keywords:  Metabolism; Model Organisms; Protocols in Metabolomics and Lipidomics
    DOI:  https://doi.org/10.1016/j.xpro.2026.104958
  14. Sci Rep. 2026 ;16 35963
      Within the Alzheimer disease (AD) spectrum, metabolic alterations occur in addition to proteinopathies. While hypometabolism is frequently observed in the late symptomatic stages, characterizing the metabolic changes during early AD stages might aid in both understanding its pathophysiology and in patient selection for future treatments. In this study, we conduct an exploratory, data-driven analysis aimed at better understanding the timing and specificity of the metabolic changes in early AD. Using kinetic analysis of [18F]FDG PET brain imaging data coming from 223 individuals, including 33 preclinical individuals and 19 symptomatic individuals, we find new evidence of a more complex spatiotemporal trajectory of glucose metabolism in early AD, which includes a paradoxical regional increase in glucose phosphorylation during preclinical AD. These findings suggest that the pathologic phases of AD parallel changes in brain glucose metabolism, which is readily assessable with [18F]FDG PET imaging. Moreover, they may indicate that metabolic interventions may work differently during preclinical AD as compared to the early symptomatic phase.
    Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1038/s41598-026-64573-x.
    Keywords:  Biomarkers; Diseases; Neurology; Neuroscience
    DOI:  https://doi.org/10.1038/s41598-026-64573-x
  15. Apoptosis. 2026 Nov 11. pii: 260. [Epub ahead of print]31(12):
       BACKGROUND: Hyperactivation of the antioxidant transcription factor Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) strongly correlates with tumor progression and poor prognosis in aggressive breast cancers. While Nrf2 is known to influence tumor metabolism, the precise molecular mechanism by which it orchestrates "metabolic plasticity", the ability to flexibly fulfill immense bioenergetic demands, remains largely elusive.
    METHODS AND RESULTS: Integrating clinical dataset analysis with in vitro genetic manipulation (MCF7 and MDA-MB-231), we confirmed Nrf2 as a core driver of breast cancer tumorigenesis. Metabolic profiling revealed that Nrf2 confers robust metabolic plasticity by concurrently upregulating both oxidative phosphorylation (OXPHOS) and glycolysis, resulting in an ATP production surge. Mechanistically, Nrf2 upregulates the expression of SIRT1, which serves as an indispensable hub for this dual metabolic enhancement. Pharmacological inhibition (using NAM or EX527) or genetic knockdown of SIRT1 effectively dismantled the Nrf2-driven metabolic advantage, drastically reducing ATP levels and suppressing colony formation. Furthermore, we uncovered an additive cytotoxic effect where combining SIRT1 inhibition with oxidative stress (H2O2) severely impaired the bioenergetic reserve and disrupted redox balance, leading to a marked suppression of cancer cell survival and clonogenic capacity.
    CONCLUSION: Our findings identify the Nrf2-SIRT1 axis as a master coordinator of metabolic plasticity in breast cancer. Repurposing SIRT1 inhibitors to disrupt this bioenergetic adaptation provides a potential, mechanism-guided rationale to sensitize therapy-resistant and Nrf2-hyperactivated breast cancer cells to oxidative stress in preclinical models.
    Keywords:  Breast cancer; Energy metabolism; Mitochondria; Nrf2; Oxidative stress; SIRT1
    DOI:  https://doi.org/10.1007/s10495-026-02471-3
  16. Nat Rev Mol Cell Biol. 2026 Nov 09.
      Timely removal of defective or superfluous cellular components, including misfolded proteins, aberrant protein complexes and damaged organelles, is essential for maintaining cellular homeostasis and adaptation to stress. This process is controlled by an intricate interplay between two principal degradation systems, the ubiquitin-proteasome system and autophagy, which together mediate the recognition, selection and elimination of diverse substrates. In this Review, we discuss how proteins and organelles are dynamically partitioned between these catabolic pathways in response to physiological demands, cellular stress and damage. We highlight the mechanisms of substrate sequestration, the spatial and temporal organization of the degradation machineries and the compensatory responses that preserve proteostasis when one pathway is compromised, including the coordination with the unfolded protein response. We also examine how selective pathways such as endoplasmic reticulum phagy and mitophagy remodel or eliminate damaged organelles. Recent advances in electron tomography have revealed the ultrastructural basis of these networks, providing insights into their architecture and dynamics. Finally, we discuss how defects in these degradation systems contribute to ageing, cancer, neurodegeneration and other pathologies.
    DOI:  https://doi.org/10.1038/s41580-026-01037-0
  17. Front Immunol. 2026 ;17 1991810
      Aberrant mechanical signals within the tumor microenvironment (TME)-including increased extracellular matrix stiffness, elevated solid stress, heightened interstitial fluid pressure, and fluid shear stress-have been established as key drivers of malignant tumor progression and metastasis. These physical cues are sensed by mechanoreceptors on the cell membrane (Piezo1, TRP channels, and integrin-FAK complexes), transmitted intracellularly through Rho GTPases and cytoskeletal dynamics, and ultimately reprogram transcriptional programs via nuclear translocation of transcriptional co-activators such as YAP/TAZ. Mechanical signals also drive metabolic reprogramming in tumor cells, particularly enhancing aerobic glycolysis (the Warburg effect), which results in massive lactate accumulation. Landmark discoveries in recent years have revealed that lactate serves as a substrate to drive histone and non-histone lactylation, directly coupling metabolic status with epigenetic regulation. Histone lactylation (e.g., H3K18la, H3K9la) activates pro-metastatic transcriptional programs by remodeling chromatin accessibility, promoting epithelial-mesenchymal transition (EMT), immune evasion, and therapeutic resistance; non-histone lactylation directly modifies cytoskeletal proteins (CFL1, vimentin, TPX2) and transcriptional regulators (Snail, YY1, PRMT1), enhancing the metastatic execution capacity of tumor cells at multiple levels, including cellular mechanical properties, migratory ability, and signal transduction. Importantly, mechanical signals, metabolic reprogramming, and lactylation constitute a mechano-metabolism-lactylation positive feedback loop, forming a self-reinforcing vicious cycle that continuously fuels tumor metastasis. This review systematically outlines the types and mechanotransduction mechanisms of TME mechanical signals, mechanically driven metabolic and transcriptional reprogramming, the multifaceted functions of lactylation in tumor metastasis, and the ultimate execution of the metastatic cascade driven by this positive feedback loop, and discusses potential therapeutic strategies targeting mechanosensitive pathways, metabolic vulnerabilities, and lactylation-modifying enzymes.
    Keywords:  YAP/TAZ; lactylation; mechanical signals; mechanotransduction; metabolic reprogramming; tumor metastasis; tumor microenvironment
    DOI:  https://doi.org/10.3389/fimmu.2026.1991810
  18. Immunology. 2026 Nov 11.
      Colorectal cancer (CRC) remains a major cause of cancer-related morbidity and mortality worldwide, with its progression and therapeutic resistance increasingly recognized as consequences of complex metabolic and immune interactions within the tumour microenvironment (TME). Recent advances in single-cell and spatial multi-omics technologies have enabled detailed characterisation of metabolic heterogeneity among TME components, uncovering how distinct metabolic states influence immune function and therapeutic responses. In this review, we summarize recent advances in our understanding of metabolic regulation in the CRC microenvironment, with a particular focus on how distinct immune cell populations contribute to tumour progression and immune suppression through diverse metabolic pathways. We discuss key metabolite-driven signalling networks involving lactate, short-chain fatty acids, bile acids, and amino acid derivatives, and examine how these pathways influence immune cell function and tumour-immune interactions. Furthermore, we highlight emerging therapeutic approaches targeting the metabolic-immune axis, including glutaminase inhibitors, CD36 antagonists, and combination regimens integrating metabolic intervention with immune checkpoint inhibitors. By integrating recent mechanistic discoveries with therapeutic perspectives, this review provides an updated overview of the metabolic-immune landscape in CRC and discusses potential strategies to exploit metabolic vulnerabilities for improving immunotherapy efficacy and overcoming treatment resistance.
    Keywords:  colorectal cancer; immunometabolism; metabolic reprogramming; tumour microenvironment
    DOI:  https://doi.org/10.1111/imm.70230
  19. Redox Biol. 2026 Nov 10. pii: S2213-2317(26)00479-9. [Epub ahead of print]98 104480
      Neutrophils are essential for innate immunity, and they must mature properly to maintain immune homeostasis. Although mitochondrial dynamics influence hematopoietic fate, how specific fusion machinery controls neutrophil development in vivo remains poorly understood. Although our earlier study suggested a role for mitofusin-2 (MFN2) in neutrophil development using cell line models, the need for MFN2 during primary hematopoietic neutrophil maturation and the associated metabolic changes have remained unclear. Using a hematopoietic-specific knockout model (MFN2flox/floxVav-iCre+/-), we found that MFN2 deletion results in the accumulation of immature neutrophils in both the bone marrow and peripheral blood. Surprisingly, MFN2 deficiency was associated with increased mitochondrial membrane potential in immature neutrophils. Super-resolution imaging showed altered mitochondrial morphology characterized by reduced elongation. Functional metabolic profiling using single-cell energetic metabolism by profiling translation inhibition (SCENITH) showed that, despite preserved overall translational activity and mitochondrial contribution, MFN2-deficient neutrophils exhibited selectively reduced utilization of non-glucose substrates, reflected by decreased fatty acid and amino acid oxidation (FAO and AAO)-supported translation in immature and mature neutrophils. Together, these findings identify an association between MFN2 deficiency, impaired neutrophil maturation, and reduced utilization of non-glucose substrates, supporting a potential link between mitochondrial substrate use and terminal neutrophil development.
    Keywords:  Fatty acid and amino acid oxidation; Mitochondria; Mitofusin; Neutrophil maturation; Neutrophils; Single-cell energetic profiling
    DOI:  https://doi.org/10.1016/j.redox.2026.104480
  20. iScience. 2026 Nov 20. 29(11): 118118
      Regular exercise and fasting are can improve brain health. How these interventions affect mitochondrial quality control processes in neurons is unknown. We hypothesized that circulating factors induced by acute exercise could stimulate neuronal mitophagy and mitochondrial remodeling.We treated primary cortical mouse neurons with serum collected from mice following a single bout of exhaustive treadmill running or sedentary controls. To determine if one bout of exercise activates brain mitophagy in vivo, we mice underwent an acute fasting and treadmill paradigm followed by electron microscopy of the frontal cortex. Proteomics analysis revealed widespread changes in mitochondrial and autophagy-related proteins and upregulation of mitochondrial biogenesis, protein quality control, and redox signaling. Acute exercise in a fasted state increased mitophagy. These results demonstrate that circulating acute exercise factors promote mitophagy and mitochondrial turnover in neurons. This supports the broader concept that exercise could enhance brain mitochondrial function.
    Keywords:  exercise; mitochondria; mitophagy; neuron
    DOI:  https://doi.org/10.1016/j.isci.2026.118118
  21. Proc Natl Acad Sci U S A. 2026 Nov 17. 123(46): e2613433123
      The electron transport chain is a signaling hub for hydrogen sulfide (H2S) that serves both as a respiratory substrate and an inhibitor. While acute sulfide toxicity is well characterized, cellular adaptations to chronic H2S, particularly microbially-derived sulfide exposure in colon, is poorly understood. We report that chronic, low-level H2S exposure (4 to 20 µM) drives robust carbon sequestration in lipid droplets (LD) across several human cell lines, driven by a coordinated remodeling of redox and nucleotide metabolism. Specifically, H2S-induced reductive shifts in nicotinamide adenine dinucleotide (NAD) and coenzyme Q (CoQ) pools are accompanied by glycerol-3-phosphate accumulation and cytidine triphosphate (CTP) depletion. Lipidomic analysis reveals increased neutral lipid synthesis and triacylglyceride accumulation concomitant with decreased CTP-dependent synthesis of membrane phospholipids. Mitochondrial expression of a water-generating NADH oxidase attenuates LD accumulation and spatially confines the origin of H2S-induced reductive stress signaling to this compartment. Interestingly, LD abundance increases even after H2S withdrawal, continuing over 48 h, during which time the reductively-shifted NAD and CoQ pools slowly reoxidize. Inhibition of fatty acid synthesis during sulfide exposure impairs cellular recovery of respiration. These findings establish an active role for LDs in stress response and reveal that lipid biogenesis is a strategy for countering H2S-induced redox imbalance. The sulfide-LD-redox axis uncovered in this study has implications for understanding how gut-derived H2S, shaped by diet and microbiome, can influence metabolic health.
    Keywords:  lipid droplet; metabolism; redox
    DOI:  https://doi.org/10.1073/pnas.2613433123
  22. Front Immunol. 2026 ;17 1883589
      Asthma is a heterogeneous disease characterized by chronic airway inflammation and airway remodeling. Growing evidence suggests that mitochondrial dysfunction is not only a consequence of inflammatory injury but may also contribute to disease persistence and progression. In asthma, mitochondrial redox balance, energy metabolism, Ca2+ homeostasis, dynamics, biogenesis, and quality control can all become dysregulated. These abnormalities are interconnected and can alter mitochondrial energy supply, structural integrity, and quality maintenance. Mitochondrial damage can increase mitochondrial reactive oxygen species, promote the mislocalization of mitochondrial nucleic acids, alter membrane lipid oxidation and remodeling, and induce the release of mitochondrial proteins and other components. These changes generate diverse mitochondria-derived damage signals that can regulate inflammation-related gene transcription, nucleic acid sensing, and inflammasome activation. More broadly, mitochondrial abnormalities also alter immune cell function, airway epithelial repair, smooth muscle cell accumulation, and extracellular matrix production. Together, these effects may contribute to persistent airway inflammation and airway remodeling. This review summarizes the major forms of mitochondrial dysfunction in asthma. It also examines how these abnormalities generate mitochondria-derived damage signals, engage inflammatory sensing, and alter immune and airway structural cell functions.
    Keywords:  airway inflammation; airway remodeling; asthma; innate immune sensing; mitochondria-derived damage signals; mitochondrial dysfunction; mitochondrial oxidative stress; mitochondrial quality control
    DOI:  https://doi.org/10.3389/fimmu.2026.1883589
  23. Cell Commun Signal. 2026 Aug 13. pii: 603. [Epub ahead of print]24(1):
       BACKGROUND: Triple-negative breast cancer (TNBC) exhibits early metastasis, a unique metabolic rigidity and poor clinical outcomes. A substantial, biomarker-definable subset of TNBC depends on glutamine metabolism, which can act as a nutrient source and a regulator of proliferation, redox homeostasis, epigenetic remodelling, and immune evasion.
    MAIN BODY: Glutamine metabolism in TNBC involves several interrelated processes, including transporter regulation, transcriptional control (FOXM1/FUS/SLC7A5 axis), and organelle-specific redox adaptation (ER-PPP/H6PD pathway). Various transporters mediate the uptake of glutamine into the cells. Once inside the cells, glutamine undergoes enzymatic conversion, driving essential metabolic pathways that support the tumor's energy needs, maintain cellular redox balance, and drive epigenetic changes that promote cancer progression. Furthermore, the tumor microenvironment, including spatial immune-metabolic competition/heterogeneity, is significantly influenced by glutamine metabolism. The availability of glutamine can regulate the behavior of immune cells, including T cells and macrophages, potentially leading to immune suppression and contributing to therapeutic resistance.
    CONCLUSION: We concluded that glutamine metabolism is a key dependency in a substantial, biomarker-definable subset of TNBC. The therapeutic potential of glutamine metabolism not only offers a promising avenue for improving treatment outcomes but also presents a means to overcome current therapeutic limitations in TNBC.
    Keywords:  Amino acid transporters; Glutamine metabolism; TNBC; Tumor microenvironment; mTORC1 signaling
    DOI:  https://doi.org/10.1186/s12964-026-03150-1
  24. Biomaterials. 2026 Nov 03. pii: S0142-9612(26)00776-3. [Epub ahead of print]339 124752
      The compensatory signal transmission between the endoplasmic reticulum (ER) and mitochondria maintains the survival of lung cancer stem cells (LCSCs). This study designed a bio-orthogonally functionalized biomimetic nanoreactor to dissociate this protective crosstalk and induce a self-amplifying stress feedback loop. By integrating an N-cadherin-targeting aptamer with tumor membrane masking technology, this nanoreactor achieves enhanced specificity for LCSCs targeting. The nanoreactor is loaded with the photosensitizer TAPP and bortezomib (BTZ). Upon laser irradiation, TAPP generates reactive oxygen species (ROS) locally, rapidly collapsing the mitochondrial membrane potential and inducing oxidative injury. Concurrently, BTZ inhibits the proteasome, blocking the degradation of ubiquitinated proteins and triggering acute ER stress, which promotes Ca2+ release into mitochondria and further exacerbates mitochondrial damage. In turn, damaged mitochondria release mitochondrial DNA (mtDNA), aggravating ER dysfunction and establishing a self-amplifying vicious cycle between the ER and mitochondria that progressively escalates cellular damage. Additionally, treatment was accompanied by reduced STAT3 phosphorylation and decreased expression of stemness-associated markers, alongside ER-mitochondrial dysfunction and enhanced cytotoxicity in stem-like cells.
    Keywords:  Bio-orthogonal click chemistry; Biomimetic nanoreactors; Calcium overload; Cancer stem cells; Endoplasmic reticulum stress; Mitochondrial stress
    DOI:  https://doi.org/10.1016/j.biomaterials.2026.124752
  25. Cell Death Dis. 2026 Aug 11. pii: 948. [Epub ahead of print]17(1):
      Disulfidptosis is a newly recognized form of non-classical cell death, characterized by the abnormal accumulation of disulfide bonds and the collapse of the cytoskeleton. Nevertheless, the regulatory mechanisms governing this process are not fully understood. Although autophagy is a crucial cellular process necessary for maintaining homeostasis, its influence on the susceptibility to disulfidptosis and the associated mechanisms is currently unknown. This study primarily explored the interaction between autophagy and disulfidptosis in hepatocellular carcinoma (HCC) cells. In this research, both a pharmacological targeting model and a gene-modified model were established for functional and mechanistic assays. The impact of autophagy on disulfidptosis was assessed both in vitro and in vivo. Our findings revealed that the inhibition of autophagic flux significantly sensitized HCC cells to disulfidptosis through metabolic reprogramming, where the suppression of autophagy resulted in the downregulation of glucose-6-phosphate dehydrogenase (G6PD) and impaired the generation of nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) and glutathione (GSH), which are critical for maintaining redox balance during disulfidptosis. Furthermore, the inhibition of autophagy also led to the suppression of mitophagy and mitochondrial dysfunction, which may further contribute to metabolic disruptions. Meanwhile, we identified endoplasmic reticulum (ER) stress as an autophagy-dependent regulator of disulfidptosis, thereby establishing a comprehensive ER stress-autophagy-disulfidptosis axis. More importantly, we repurposed the clinical drug clofazimine as a novel disruptor of the equilibrium between ER stress and autophagy, which significantly enhances disulfidptosis in preclinical HCC models. These results improve our understanding of the regulation of disulfidptosis and provide evidence that autophagy acts as a principal suppressor of disulfidptosis, suggesting that pharmacological targeting of the homeostasis between ER stress and autophagy may represent a promising therapeutic approach for the treatment of HCC.
    DOI:  https://doi.org/10.1038/s41419-026-09135-9
  26. PLoS One. 2026 ;21(11): e0360503
       BACKGROUND: Metabolic adaptation is a crucial driver of melanoma progression and therapy resistance. The pseudokinase Tribbles homolog 2 (TRIB2) is highly expressed in melanoma and is associated with poor outcomes and treatment resistance. However, its specific role in the metabolic profile of melanoma cells remained unexplored. This study aimed to investigate the impact of TRIB2 on cellular metabolism, and its role in metabolic adaptation in melanoma.
    MATERIALS AND METHODS: The study used UACC-62 human melanoma cells with high endogenous TRIB2 expression and isogenic TRIB2-knockout (KO) clones generated via CRISPR-Cas9. Cell proliferation was assessed using trypan blue exclusion assays under treatment with metabolic drugs including 2-deoxyglucose (2-DG), and dichloroacetate (DCA). Metabolic phenotypes were evaluated by measuring glucose consumption, lactate production, and real-time analysis of glycolytic flux (ECAR) and mitochondrial respiration (OCR) using a Seahorse bioanalyzer. Reactive oxygen species (ROS) levels were measured by dihydroethidium (DHE) fluorescence. Gene expression was analyzed by qPCR, and protein levels were determined by western blot. Citrate synthase activity was measured enzymatically.
    RESULTS: TRIB2-KO cells exhibited significantly reduced basal proliferation compared with wild-type (WT) cells. KO cells were also more sensitive to the glycolytic inhibitor 2-DG. Conversely, WT cells were more susceptible to DCA treatment. Metabolic analyses confirmed that TRIB2-KO cells had lower glucose consumption, lactate production, and glycolytic capacity than WT cells. Mitochondrial respiratory function and the protein levels of key respiratory complexes were unchanged. Despite the reduction in glycolytic activity, TRIB2 depletion did not increase mitochondrial respiratory capacity and was associated with elevated basal intracellular superoxide levels. Among the molecular alterations identified, PDK4 was consistently reduced at both the mRNA and protein levels, whereas citrate synthase activity was significantly decreased despite preserved protein abundance, indicating selective alterations in mitochondrial carbon metabolism.
    CONCLUSIONS: TRIB2 expression promotes a glycolytic phenotype and contributes to metabolic adaptation in melanoma. Loss of TRIB2 does not induce a metabolic shift towards oxidative phosphorylation but instead results in broader metabolic rewiring characterized by reduced glycolysis together with selective alterations in mitochondrial carbon metabolism. These findings identify the TRIB2-PDK4 axis as a previously unrecognized component of metabolic regulation in melanoma and provide a rationale for further investigating its therapeutic potential.
    DOI:  https://doi.org/10.1371/journal.pone.0360503
  27. Clin Exp Immunol. 2026 Nov 10. pii: uxag075. [Epub ahead of print]
      Cellular metabolism is now recognised as an active regulator of immune cell activation, differentiation, and function. However, much of this conceptual framework derives from in vitro systems and animal models that may not fully reproduce human physiology or disease. Many studies of human immune metabolism are constrained by artificial culture conditions, tissue dissociation, limited pathway coverage, and a reliance on static measurements that do not directly quantify metabolic flux in vivo. Interpretation is further complicated by the use of blood samples as a surrogate for diseases that arise in specialised tissues, such as synovium, gut, and skin, and by the influence of systemic physiology, including hepatic substrate regulation, adipose tissue, endocrine and neuronal signalling, and the gut microbiota. In this review, we examine what current experimental approaches can infer about immune metabolism in humans, with a focus on immune-mediated inflammatory diseases. Oncology provides a valuable methodological precedent through its use of tissue sampling, spatial profiling, and stable isotope tracing, while also illustrating the challenges of assigning metabolic activity to individual cell populations within heterogeneous tissues. We propose five priorities for the field: move beyond blood to inflammatory tissue; complement static abundance with dynamic, stable isotope flux analysis; integrate single cell, spatial, and imaging modalities; incorporate carefully designed human metabolic perturbations; and account for the wider systemic and pre-analytical context. The next phase of human immunometabolism should move from pathway annotation in reductionist models towards dynamic, tissue-resolved, and clinically anchored studies of immune cell metabolism in vivo.
    Keywords:  Immunometabolism; immune-mediated inflammatory diseases; metabolic flux; spatial metabolomics; stable isotope tracing
    DOI:  https://doi.org/10.1093/cei/uxag075